160 related articles for article (PubMed ID: 30260268)
1. Effectiveness of zolpidem and sleep hygiene counseling in the treatment of insomnia in solid tumor patients.
Asok A; Sreekumar S; Tk R; Cc A; P UD; K P
J Oncol Pharm Pract; 2019 Oct; 25(7):1608-1612. PubMed ID: 30260268
[TBL] [Abstract][Full Text] [Related]
2. Doxepin is more effective than zolpidem in improving executive function in patients with insomnia disorder.
Yu Z; Han L; Yan P; Liu W; Ren L; Xu Y; Yang L; Ma L; Liu Y; Wang S
Sleep Breath; 2024 May; 28(2):929-934. PubMed ID: 38123719
[TBL] [Abstract][Full Text] [Related]
3. Zolpidem: Efficacy and Side Effects for Insomnia.
Edinoff AN; Wu N; Ghaffar YT; Prejean R; Gremillion R; Cogburn M; Chami AA; Kaye AM; Kaye AD
Health Psychol Res; 2021; 9(1):24927. PubMed ID: 34746488
[TBL] [Abstract][Full Text] [Related]
4. Effects of zolpidem on sleep parameters in patients with cirrhosis and sleep disturbances: A randomized, placebo-controlled trial.
Sharma MK; Kainth S; Kumar S; Bhardwaj A; Agarwal HK; Maiwall R; Jamwal KD; Shasthry SM; Jindal A; Choudhary A; Anand L; Dhamija RM; Kumar G; Sharma BC; Sarin SK
Clin Mol Hepatol; 2019 Jun; 25(2):199-209. PubMed ID: 30856689
[TBL] [Abstract][Full Text] [Related]
5. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study.
Dorsey CM; Lee KA; Scharf MB
Clin Ther; 2004 Oct; 26(10):1578-86. PubMed ID: 15598474
[TBL] [Abstract][Full Text] [Related]
6. Effect and safety of paroxetine combined with zolpidem in treatment of primary insomnia.
Yu ZH; Xu XH; Wang SD; Song MF; Liu Y; Yin Y; Mao HJ; Tang GZ
Sleep Breath; 2017 Mar; 21(1):191-195. PubMed ID: 28101753
[TBL] [Abstract][Full Text] [Related]
7. Intervention effect of electroacupuncture therapy on drug reducing and discontinuation of insomnia patients with long-term excessive use of zolpidem.
Zhang H; Rong H; Xiong S; Chen X; Lin Z
Explore (NY); 2024; 20(3):328-333. PubMed ID: 37775407
[TBL] [Abstract][Full Text] [Related]
8. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T
J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
[TBL] [Abstract][Full Text] [Related]
9. A double-blind, randomized, comparative study to evaluate the efficacy and safety of zaleplon versus zolpidem in shortening sleep latency in primary insomnia.
Huang YS; Hsu SC; Liu SI; Chen CK
Chang Gung Med J; 2011; 34(1):50-6. PubMed ID: 21392474
[TBL] [Abstract][Full Text] [Related]
10. Zolpidem in the treatment of short-term insomnia: a randomized, double-blind, placebo-controlled clinical trial.
Dockhorn RJ; Dockhorn DW
Clin Neuropharmacol; 1996 Aug; 19(4):333-40. PubMed ID: 8828996
[TBL] [Abstract][Full Text] [Related]
11. Subjective versus objective evaluation of hypnotic efficacy: experience with zolpidem.
Kryger MH; Steljes D; Pouliot Z; Neufeld H; Odynski T
Sleep; 1991 Oct; 14(5):399-407. PubMed ID: 1759092
[TBL] [Abstract][Full Text] [Related]
12. Insomnia: zolpidem extended-release for the treatment of sleep induction and sleep maintenance symptoms.
Doghramji PP
MedGenMed; 2007 Jan; 9(1):11. PubMed ID: 17435620
[TBL] [Abstract][Full Text] [Related]
13. Zolpidem extended-release: a single insomnia treatment option for sleep induction and sleep maintenance symptoms.
Barkin RL
Am J Ther; 2007; 14(3):299-305. PubMed ID: 17515707
[TBL] [Abstract][Full Text] [Related]
14. Placebo-controlled sleep laboratory studies on the acute effects of zolpidem on objective and subjective sleep and awakening quality in nonorganic insomnia related to neurotic and stress-related disorder.
Saletu-Zyhlarz G; Anderer P; Brandstätter N; Dantendorfer K; Gruber G; Mandl M; Ritter K; Zoghlami A; Saletu B
Neuropsychobiology; 2000; 41(3):139-48. PubMed ID: 10754428
[TBL] [Abstract][Full Text] [Related]
15. Randomized, double blind trial of zolpidem 10 mg versus triazolam 0.25 mg for treatment of insomnia in general practice.
Rosenberg J; Ahlstrøm F
Scand J Prim Health Care; 1994 Jun; 12(2):88-92. PubMed ID: 7973199
[TBL] [Abstract][Full Text] [Related]
16. Effect of Zolpidem on Sleep Quality of Professional Firefighters; a Double Blind, Randomized, Placebo-Controlled Crossover Clinical Trial.
Mehrdad R; Sadeghniiat Haghighi K; Naseri Esfahani AH
Acta Med Iran; 2015; 53(9):573-8. PubMed ID: 26553086
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
Roth T; Soubrane C; Titeux L; Walsh JK;
Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
[TBL] [Abstract][Full Text] [Related]
18. A 2-week efficacy and safety study of gaboxadol and zolpidem using electronic diaries in primary insomnia outpatients.
Hajak G; Hedner J; Eglin M; Loft H; Stórustovu SI; Lütolf S; Lundahl J;
Sleep Med; 2009 Aug; 10(7):705-12. PubMed ID: 19346160
[TBL] [Abstract][Full Text] [Related]
19. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
Scharf MB; Roth T; Vogel GW; Walsh JK
J Clin Psychiatry; 1994 May; 55(5):192-9. PubMed ID: 8071269
[TBL] [Abstract][Full Text] [Related]
20. Zolpidem in the treatment of transient insomnia: a double-blind, randomized comparison with placebo.
Roth T; Roehrs T; Vogel G
Sleep; 1995 May; 18(4):246-51. PubMed ID: 7618022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
